Cotrim Helma P, Parise Edison R, Figueiredo-Mendes Cláudio, Galizzi-Filho João, Porta Gilda, Oliveira Claudia P
Grupo Brasileiro de Estudos do NAFLD, Sociedade Brasileira de Hepatologia, Brasil; , Grupo Brasileiro de Estudos do NAFLD, Brasil.
Universidade Federal da Bahia, Salvador, BA, Brasil; , Universidade Federal da Bahia, Universidade Federal da Bahia, Salvador BA , Brazil.
Arq Gastroenterol. 2016 Apr-Jun;53(2):118-22. doi: 10.1590/S0004-28032016000200013.
The prevalence of obesity-related metabolic syndrome has rapidly increased in Brazil, resulting in a high frequency of nonalcoholic fatty liver disease, that didn't receive much attention in the past. However, it has received increased attention since this disease was identified to progress to end-stage liver diseases, such as cirrhosis and hepatocellular carcinoma. Clinical practice guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease have not been established in Brazil. The Brazilian Society of Hepatology held an event with specialists' members from all over Brazil with the purpose of producing guideline for Nonalcoholic Fatty Liver Disease based on a systematic approach that reflects evidence-based medicine and expert opinions. The guideline discussed the following subjects: 1-Concepts and recommendations; 2-Diagnosis; 3-Non-medical treatment; 4-Medical treatment; 5-Pediatrics - Diagnosis; 6-Pediatrics - Non-medical treatment; 7-Pediatrics - Medical treatment; 8-Surgical treatment.
在巴西,与肥胖相关的代谢综合征患病率迅速上升,导致非酒精性脂肪性肝病的发病率居高不下,而这种疾病在过去并未受到太多关注。然而,自从该疾病被认定会发展为肝硬化和肝细胞癌等终末期肝病以来,它受到了越来越多的关注。巴西尚未制定非酒精性脂肪性肝病的诊断和治疗临床实践指南。巴西肝病学会举办了一次活动,邀请了来自巴西各地的专家成员,旨在基于反映循证医学和专家意见的系统方法,制定非酒精性脂肪性肝病指南。该指南讨论了以下主题:1. 概念与建议;2. 诊断;3. 非药物治疗;4. 药物治疗;5. 儿科 - 诊断;6. 儿科 - 非药物治疗;7. 儿科 - 药物治疗;8. 手术治疗。